The South America sepsis diagnostics market is expected to grow from US$ 38.66 million in 2021 to US$ 69.59 million by 2028; it is estimated to grow at a CAGR of 8.8% from 2021 to 2028.
Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. Thus, the rising bloodstream infections will increase the adoption of sepsis diagnostic products. Sepsis has a high mortality and morbidity rate. According to an article published by the National Center for Biotechnology Information (NCBI) in February 2019, sepsis mortality rate was ~25-30%. Additionally, in September 2020, the World Health Organization (WHO) estimated that each year almost 50% of cases of sepsis occur among children, resulting in 2.9 million deaths. Most deaths can be prevented through early diagnosis and appropriate clinical management. These deaths are often a consequence of diarrheal diseases or lower respiratory infections. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, thereby supporting the sepsis diagnostics market growth during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America sepsis diagnostics market. The South America sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.
Key players operating in the South America sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. by Altair.
Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. Thus, the rising bloodstream infections will increase the adoption of sepsis diagnostic products. Sepsis has a high mortality and morbidity rate. According to an article published by the National Center for Biotechnology Information (NCBI) in February 2019, sepsis mortality rate was ~25-30%. Additionally, in September 2020, the World Health Organization (WHO) estimated that each year almost 50% of cases of sepsis occur among children, resulting in 2.9 million deaths. Most deaths can be prevented through early diagnosis and appropriate clinical management. These deaths are often a consequence of diarrheal diseases or lower respiratory infections. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, thereby supporting the sepsis diagnostics market growth during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South America sepsis diagnostics market. The South America sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.
South America Sepsis Diagnostics Market Segmentation
The South America sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media segment dominated the South America sepsis diagnostics market in 2021. In terms of technology, the market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the South America sepsis diagnostics market in 2021. Based on method, the South America sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the market in 2021. Based on test type, the South America sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the market in 2021. In terms of pathogen, the South America sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the market in 2021. Based on end user, the South America sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the market in 2021. Based on country, the South America sepsis diagnostics market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America sepsis diagnostics market in 2021.Key players operating in the South America sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. by Altair.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Sepsis Diagnostics Market - By Product
1.3.2 SAM Sepsis Diagnostics Market - By Technology
1.3.3 SAM Sepsis Diagnostics Market - By Method
1.3.4 SAM Sepsis Diagnostics Market - By Test Type
1.3.5 SAM Sepsis Diagnostics Market - By Pathogen
1.3.6 SAM Sepsis Diagnostics Market - By End User
1.3.7 SAM Sepsis Diagnostics Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Sepsis Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Sepsis Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. Sepsis Diagnostics Market- SAM Analysis
6.1 SAM Sepsis Diagnostics Market Revenue Forecast and Analysis
7. SAM Sepsis Diagnostics Market - By Product
7.1 Overview
7.2 SAM Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. SAM Sepsis Diagnostics Market - By Technology
8.1 Overview
8.2 SAM Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. SAM Sepsis Diagnostics Market - By Method
9.1 Overview
9.2 SAM Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. SAM Sepsis Diagnostics Market - By Test Type
10.1 Overview
10.2 SAM Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. SAM Sepsis Diagnostics Market - By Pathogen
11.1 Overview
11.2 SAM Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. SAM Sepsis Diagnostics Market - By End User
12.1 Overview
12.2 SAM Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. SAM Sepsis Diagnostics Market - By Country Analysis
13.1 South And Central America Sepsis Diagnostics Market Revenue and Forecasts To 2028
13.1.1 Overview
13.1.2 SAM Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
13.1.2.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.1.3 Brazil: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.1.4 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.1.4.1 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.1.5 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.1.6 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.1.7 Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.1.8 Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
13.1.2.2.3 Argentina: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.2.4 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.2.4.1 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.2.5 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.2.6 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.2.7 Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.2.8 Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
13.1.2.3 Rest of South and Central America: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
13.1.2.3.1 Overview
13.1.2.3.2 Rest of SAM: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
13.1.2.3.3 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts To 2028, By Product (US$ Million)
13.1.2.3.4 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.3.4.1 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.3.5 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.3.6 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.3.7 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.3.8 Rest of SAM: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
14. Sepsis Diagnostics Market-Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms
List of Figures
Figure 1. SAM Sepsis Diagnostics Market Segmentation
Figure 2. SAM Sepsis Diagnostics Market, By Country
Figure 3. SAM Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. SAM: PEST Analysis
Figure 7. SAM Experts Opinion
Figure 8. SAM Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. SAM Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. SAM Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. SAM Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. SAM Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. SAM Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. SAM Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. SAM Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. SAM Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. SAM Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. SAM Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. SAM Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. SAM Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. SAM Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. SAM Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. SAM Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. SAM Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. SAM Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. SAM Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 27. SAM Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. SAM Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. SAM Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 30. SAM Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. SAM Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. SAM Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 33. SAM Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. SAM Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. SAM Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. SAM Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 37. SAM Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. SAM Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. SAM Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. South and Central America Sepsis Diagnostics Market Revenue Overview, by Key Country, 2021 (US$ Million)
Figure 41. SAM Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
Figure 42. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 43. Argentina Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 44. Rest of SAM: Sepsis Diagnostics Market- Revenue and Forecast to 2028 (US$ Mn)
Figure 45. Growth Strategies in the Sepsis Diagnostics Market (%)List of Tables
Table 1. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 2. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 3. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 4. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 5. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 6. Brazil: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 7. Brazil: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 8. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 9. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 10. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 11. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 12. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 13. Argentina: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 14. Argentina: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 15. Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 16. Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 17. Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 18. Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 19. Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 20. Rest of SAM: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 21. Rest of SAM: Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 22. Organic Developments in the Sepsis Diagnostics Market
Table 23. Inorganic Developments in the Sepsis Diagnostics Market
Table 24. Glossary of Terms
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- F. HOFFMANN-LA ROCHE LTD.
- Immunexpress Inc.
- BD
- Danaher (Beckman Coulter)
- Luminex Corporation
- THERMO FISHER SCIENTIFIC INC.
- bioMerieux SA
- T2 Biosystems, Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 172 |
| Published | August 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 38.66 Million |
| Forecasted Market Value ( USD | $ 69.59 Million |
| Compound Annual Growth Rate | 8.8% |
